by Cory Nealon, University at Buffalo Graphical Abstract. Credit: Cell Reports Medicine (2024). DOI: 10.1016/j.xcrm.2024.101433Recombinant protein vaccines, like the Novavax vaccine used to fight COVID-19, offer several advantages over conventional vaccines. They’re easy to produce precisely. They’re safe and potentially more effective. And they could require smaller doses. Because of these traits, there is much interest...
